MD Anderson Cancer Center/University of Texas MDACC — Houston, Texas

MD Anderson Cancer Center/University of Texas MDACC is a clinical research site located in Houston, Texas, United States 77030.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

MD Anderson Cancer Center/University of Texas MDACC has participated in 2 clinical trials.

Therapeutic areas: Acute Lymphoblastic Leukemia (ALL), Diffuse Large B-cell Lymphoma (DLBCL), Breast Cancer.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MD Anderson Cancer Center/University of Texas MDACC?

MD Anderson Cancer Center/University of Texas MDACC has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MD Anderson Cancer Center/University of Texas MDACC conducted?

MD Anderson Cancer Center/University of Texas MDACC has 2 clinical trials on record. Their work covers Acute Lymphoblastic Leukemia (ALL), Diffuse Large B-cell Lymphoma (DLBCL), Breast Cancer.

Is MD Anderson Cancer Center/University of Texas MDACC accredited by Crixeo Health?

MD Anderson Cancer Center/University of Texas MDACC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MD Anderson Cancer Center/University of Texas MDACC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.